Asia Pacific Cancer Screening Market Analysis 2020-2030
The Asia Pacific cancer screening market is anticipated to grow with a CAGR of 13.37% during the forecast period, i.e., 2021-2030. Factors such as the growing medical industry in the region, along with the increasing health expenditure, and the growing advancements in the field of healthcare technologies, are anticipated to drive the market growth in the coming years. Additionally, factors such as the rising incidences of cancer and the growing developments in cancer screening technologies are also projected to contribute to the market growth during the forecast period. The Asia Pacific cancer screening market is estimated to garner a revenue of more than USD 142540 Million by the end of 2030, up from a revenue of about USD 40980 Million in the year 2020.
The Asia Pacific cancer screening market is segmented by numerous segments, which include segmentation by screening type, product, application, end-user, and by country. By screening type, the market is segmented into laboratory tests, genetic tests, imaging, biopsy, endoscopy, and others. By the end of 2030, the imaging segment is projected to garner the largest revenue of close to USD 52360 Million, up from a revenue of about USD 15040 Million in the year 2020.
On the basis of country, the Asia Pacific cancer screening market is segmented into Australia, Japan, Singapore, South Korea, India, China, Taiwan, Vietnam, Thailand, Philippines, and the Rest of Asia Pacific. The market in China, amongst the market in all the other regions, is anticipated to garner the largest revenue of near to USD 62860 Million by the end of 2030. Moreover, in the year 2020, the market in the nation generated a revenue of about USD 17370 Million.
Some of the prominent industry leaders in the Asia Pacific cancer screening market that are included in our report are Abbott, General Electric, Hologic, Inc., Siemens Healthcare Private Limited, QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Novacyt Group, Koninklijke Philips N.V., MiRXES Pte Ltd., and others.
Table of Contents
1. Market Definition
3. Research Methodology
5. Analysis of Market Dynamics
15. Asia Pacific Cancer Screening Market 2020-2030
16. Australia Cancer Screening Market 2020-2030
17. Japan Cancer Screening Market 2020-2030
18. Singapore Cancer Screening Market 2020-2030
19. South Korea Cancer Screening Market 2020-2030
20. India Cancer Screening Market 2020-2030
21. China Cancer Screening Market 2020-2030
22. Taiwan Cancer Screening Market 2020-2030
23. Vietnam Cancer Screening Market 2020-2030
24. Thailand Cancer Screening Market 2020-2030
25. Philippines Cancer Screening Market 2020-2030
26. Rest of Asia Pacific Cancer Screening Market 2020-2030
27. Competitive Landscape
Companies Mentioned
- Abbott
- General Electric
- Hologic Inc.
- Siemens Healthcare Private Limited
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Novacyt Group
- Koninklijke Philips N.V.
- MiRXES Pte Ltd.